In the Matter of Carrot Neurotechnology, Inc., File No. 1423132 #00054

Submission Number:
00054
Commenter:
Pamela Butler
State:
New York
Initiative Name:
In the Matter of Carrot Neurotechnology, Inc., File No. 1423132
To the FTC: I am writing regarding Ultimeyes made by Carrot Technology. Seitz and colleagues have published several studies which support the claim that Ultimeyes improves vision. Improvement was seen in visual acuity, contrast sensitivity, as well as reading and sports performance. In addition, there is a literature showing efficacy of similar visual training techniques. While placebo controlled trials will be useful, the current research is peer-reviewed, well-done, and provides evidence for improvement in visual function. The fine imposed ($150,000) by the FTC is not justified in light of scientific evidence of efficacy. It also sets a dangerous precedent of dissuading investigators from making their products available to the public. A much better solution would be to come to an agreement with Carrot Technology to revise the advertising. I do not think there should be a fine and believe the FTC should re-consider the matter. Sincerely, Pamela Butler, PhD